Agenus and Zydus transactions face new CFIUS review, closing shifts to Q4
NeutralFinancial Markets

Agenus and Zydus are facing a new review by the Committee on Foreign Investment in the United States (CFIUS), which has led to a shift in the expected closing date of their transactions to the fourth quarter. This review is significant as it highlights the ongoing scrutiny of foreign investments in U.S. companies, particularly in sensitive sectors like biotechnology. Stakeholders will be watching closely to see how this impacts the companies involved and the broader investment landscape.
— Curated by the World Pulse Now AI Editorial System